Vira Regen Competitors and Similar CompaniesClear all

CureVac's competitors and similar companies include Deciphera Pharmaceuticals and AnaptysBio.

	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.	Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.	AnaptysBio AnaptysBio is a biotechnology company developing immunology therapeutic product candidates.
Founding Date	Founding Date 2000	Founding Date 2003	Founding Date 2005
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US	Locations Waltham, US HQ Lawrence, US	Locations San Diego, US HQ San Diego, US
Employees	Employees 82517% decrease	Employees 35037% increase	Employees 898% decrease
Valuation ($)	Valuation ($) 648.3 m	Valuation ($) 2.2 b	Valuation ($) 930.2 m
Financial
Revenue (est.)	Revenue (est.) €535.2m (FY, 2024)	Revenue (est.) $163.4m (FY, 2023)	Revenue (est.) $234.6m (FY, 2025)
Cost of goods	Cost of goods €9.7m (FY, 2024)	Cost of goods $3.7m (FY, 2023)	Cost of goods N/A
Gross profit	Gross profit €534.4m (FY, 2024)	Gross profit $159.6m (FY, 2023)	Gross profit N/A
Net income	Net income €162.2m (FY, 2024)	Net income ($194.9m) (FY, 2023)	Net income N/A
Operating ⚠
Patent Applications	Patent Applications 500 (Mar, 2020)	Patent Applications 49 (Aug, 2017)	Patent Applications N/A
Funding
Total funding raised	Total funding raised $ 1.1b	Total funding raised $ 714m	Total funding raised $ 83.9m